Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alvotech PIPE Financing Round Overshoots By $21m

Icelandic Firm Now Anticipates $475m Gross Proceeds Via SPAC Merger

20 Jan 2022

• By Dean Rudge

fund raising — Alvogen is set to merge with a black check company • Source: Alamy

Related Content

Teva Confident On US Adalimumab Filing Amid Alvotech Advantages

13 Jan 2022

Alvotech Eyes Canada Humira Launch As Celltrion Also Bags High-Strength Approval

11 Jan 2022

Alvotech Welcomes EU Endorsement Of Higher-Strength Adalimumab

16 Dec 2021

Alvotech Differentiation Plans Include Interchangeable Golimumab

09 Dec 2021

Alvotech Eyes $450m Funding And Public Listing With SPAC Merger

08 Dec 2021

Finance Watch: SPACs Lose Their Luster As Difficulties Mount

18 Jan 2022

Related Companies

Alvotech

More from Archive

More from Generics Bulletin

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.